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Abstract
Background: In Africa, herbal medicines are often used as primary treatment for Human immunodeficiency virus
(HIV) related problems. Concurrent use of traditional herbal medicines (THM) with antiretroviral drugs (ARVs) is
widespread among HIV infected patients. However, the extent of THM use is not known in most settings in Sub-
Saharan Africa. This study aimed at determining the prevalence and factors associated with THM use among HIV
infected patients on highly active antiretroviral therapy (HAART) attending The AIDS Support Organization (TASO)
in Uganda. TASO is a non-governmental organization devoted to offering HIV/AIDS care and treatment services in
the population.
Methods: This was a cross-sectional study carried out in two TASO treatment centres in Uganda among 401
randomly selected eligible participants. We included participants who were 18 years and above, were enrolled on
HAART, and consented to participate in the study. Data was collected using an interviewer-administered semi-
structured questionnaire. THM use referred to someone who had ever used or was currently using herbal medicine
while on highly active antiretroviral therapy (HAART) by the time of the study. Data was captured in Epi-data
version 3.1 and exported to STATA version 9.0 for analysis.
Results: The prevalence of THM use was 33.7%. Patients on HAART for < 4 years were more likely to use THM (OR =
5.98, 95% CI 1.13 - 31.73) as well as those who experienced HAART side effects (OR = 3.66, 95% CI: 1.15 - 11.68). Older
patients (≥39 years) were less likely to use THM (OR = 0.26 95% CI: 0.08 - 0.83). Participants with HAART adherence
levels > 95% were less likely to use THM (OR = 0.09, 95% CI 0.01 - 0.65).
Conclusion: The prevalence of THM use among participants on HAART was high. This raises clinical and
pharmacological concerns that need attention by the health care service providers.
Background
Worldwide, more than 40 million people are infected
with Human immunodeficiency virus (HIV) [1] and
more than 20 million deaths have been attributed to
Acquired immunodeficiency syndrome (AIDS) since the
onset of the HIV pandemic [2]. Globally there were over
3 million people in low middle income countries and 2
million in the Sub-Saharan Africa on HAART by 2002-
2007[2]. In Uganda, there are over 1 million people with
HIV and of these more than 312,000 need HAART, but
only about 212,200 have access to the drugs[3].
The introduction of highly active antiretroviral therapy
(HAART) has led to reduction in AIDS-related morbid-
ity and mortality[4]. However the management of
HAART side effects has remained a challenge in many
resource limited settings[5], hence the increased use of
complementary and alternative medicine (CAM).
CAM can be defined as any treatment used in con-
junction (complementary) or in place of (alternative)
standard medical treatment [6]. In Canada, complemen-
tary and alternative medicine (CAM) use, was most
common in out-patients that reported HAART-related
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Organization (WHO) estimates that 4 billion people,
which is 80% of the world’s population, presently use her-
bal medicines for some aspect of primary health care in
conjunction with conventional medicines [6]. In Africa,
the majority of HIV patients rely on traditional herbal
medicine (THM) for management of side effects and other
primary health care needs[8,9]. Some studies have
reported large numbers of traditional health practices
(THPs) in the treatment of HIV/AIDS in developing coun-
tries involved in the treatment of HIV/AIDS [3]. In addi-
tion, some African nations such as South Africa, the
Ministry of Health is currently promoting the use of tradi-
tional medicines for the treatment of HIV and associated
symptoms [10] In the case of South Africa, the Ministry of
Health is actively promoting the use of traditional medi-
cines concurrently with antiretroviral treatments [10].
Concurrent use of THM and antiretroviral drugs may
lead to drug interactions that may interfere with the
effectiveness of HAART [11]. Previous studies have
found that HIV-infected patients who distrust their
health care providers are more likely to use CAM as a
substitute for conventional HIV therapy[12]. In addition,
HIV-infected patients with a greater desire for medical
information and a negative attitude toward the effective-
ness of antiretrovirals are more likely to use CAM with
potential for adverse effects [12]. However, the extent
and factors associated with herbal medicine use among
HIV/AIDs patients on HAART is not well documented
in Uganda. Consequently there are no clear guidelines
on herbal medicine use among HAART patients in
Uganda. This study was therefore conducted to deter-
mine the prevalence and factors associated with THM
use among HIV infected patients on HAART attending
The AIDS Support Organization (TASo) in Uganda.
Study site description
TASO is a leading non-governmental HIV/AIDS organi-
zation with over 18,000 clients initiated on HAART by
the end of 2007. It has 11 treatment centres country
wide that provide free counseling and medical care to
all people who seek their services. Each centre serves a
population from a radius of about 75 kms.
Methods
Study design
A cross-sectional study was conducted among 401
patients on HAART at two TASO treatment centres in
Jinja and Entebbe from January to March 2008.
Subject Selection
The two sites were conveniently selected. The study
participants from the centres were selected by simple
random sampling method using MS EXCEL ("RAND
function”) computer generated random numbers. The
patients’ registration numbers from the HAART refill
database for each centre were used to generate the
random numbers. All numbers similar to those
assigned to the patients’ registration numbers were
chosen until the required sample size was achieved.
We selected 233 participants from Jinja and 168 from
Entebbe. The sampled numbers were based on the cli-
entele load at each site.
Patients were eligible for participation in our study if
they were on HAART, were aged 18years and above,
and consented to participate in the study. Seven patients
refused to consent and 13 patients that had consented
refused to respond to most of the study questions. The
latter were replaced
Data collection
Participant data were collected using a pilot-tested
interviewer-administered semi-structured questionnaire
developed specifically for the research. The data was
collected by six trained research assistants (3 in each
TASO centre) under direct supervision of the principal
investigator. The outcome measure was traditional
herbal medicine use. This referred to someone who
had ever used or was currently using herbs that con-
tain active ingredients of; parts of plants, or plant
material or a combination of both while on HAART.
Participants were asked when and why they started
using THM, what herb was taken, how often they used
it and whether they had disclosed this use to the
clinicians.
Data was also collected on; demographic characteris-
tics of the participants including age, sex, religion, high-
est level of education attained, occupation, marital
status and religion; drug related factors including adher-
ence to HAART, duration on HAART, and side effects;
individual factors including familiarity with herbs, sexual
activity, risky sexual behaviors, beliefs in the usefulness
of THM, disclosure of HIV status, knowledge about
HAART, and perceived health status while on HAART;
clinical characteristics including CD4 cell counts, weight
gain and having opportunistic infections; and health ser-
vice related factors including type of information got
from the counselors, method of counseling and patient
doctor relationship.
Respondents were asked when and why they started
using THM, what herb was taken and how often among
others. We also tried to find out if THM use was dis-
closed to the clinicians. Medical and counseling records
were crosschecked to verify the data got from the parti-
cipants on the clinical, drug related and some of the
individual factors like sexual behaviors
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The study was approved by the Makerere University
College of Health Sciences Medicine Research and
Ethics Committee. The study included only patients that
had given informed consent before data collection.
We ensured confidentiality of the participants’ infor-
mation using numbers instead of the participants’
names as well as using persons that were not employed
at these centers to collect the data.
Statistical issues
Sample size calculation was based on the assumption
that 19% [13] of HAART patients in Uganda with
HAART related side effects use traditional herbal medi-
cine, a significance level, of 0.05 and a power of 0.80.
We computed sample size using Kish Leslie (1965)
formula and Epi-Info STATCALC. In order to have ade-
quate power and two-sided testing for associations, a
minimum sample size of 400 was required.
The data was captured using EPI-data version 3.1(The
EpiData Association, Odense, Denmark) and exported to
STATA 9.0 (Stata, College Station, TX, USA) for
statistical analysis. Descriptive statistics were used to
summarize baseline characteristics and to determine the
prevalence of THM use. Bivariate analysis was used to
determine the factors associated with THM appropri-
ately using either chi-square tests or Fisher’s exact tests.
A p-value less than 0.05, was considered significant. To
determine factors that are independently associated with
THM use, variables with P < 0.2 at bivariate analysis
was entered into the logistic regression model for
further analysis. We assessed for interaction using the
chunk test to compare negative two log likelihoods of
full and reduced models. We considered confounding
present if there was a difference of at least 10% between
crude and adjusted odds ratios. On the other hand, over
63% of the adherence data from the participants’ indivi-
dual files was missing and this could have affected our
findings.
Results
Descriptive results
We enrolled 401 participants enrolled on HAART, 280
(69.8%) were women and the median age was 39 years
(IQR 18.78) (Table 1). The majority of the respondents
had attained primary level education, (n = 204, 50.9%).
About thirty percent were married and almost half were
self-employed (n = 195, 48.6%).
Prevalence of THM use
The prevalence of THM use was 33.7%, (95% CI: 33.38-
34.02), (Table 2). THM use was similar among patients
at the two centers but was higher among women com-
pared to men (36.4% versus 27.3% respectively).
Reasons most stated for THM use were to reduce con-
stant fever (67.4%) and treat cough (65.2%), (Table 3).
Most of the herbs were obtained from registered herbalist
(69.6%) and very few (5.2%) were obtained from pharma-
cies. Of the 135 patients on HAART who reported using
THM, 130 (96.3%) perceived better health where the
majority 63 (46.7%) got the herbs from the registered
herbalists, (Table 4). The herbs used ranged from locally
mixed stems, wood barks, leaves, food supplements and
personal/individual morning urine (11.1%).
Bivariate analysis
Single individuals were more likely to use THM com-
pared to the married individuals (P = 0.006), (Table 5).
The participants who were ≥ 39 years were less likely to
use THM than those who were ≤ 38 years, (P = 0.002).
Participants who reported side effects from HAART were
t w ot i m e sm o r el i k e l yt ou s eT H Mc o m p a r e dt ot h o s e
who did not, (Table 6). Individuals who had been on
HAART for < 4 years were more likely to use herbs than
those who were on HAART for ≥ 4 years, (P = 0.048).
Patients who could not tell if herbs actually improved
Table 1 Characteristics of patients on HAART at TASO
Uganda, during 2008
Characteristic Frequency Percentage
Women 280 69.8
Men 121 30.2
Median age (IQR) 11 2.74
Education level
None 54 13.5
Primary 204 50.9
Secondary 130 32.4
Tertiary 13 3.24
Religion
Catholic 109 27.2
Anglican 132 32.9
Muslim 73 18.2
Pentecost 77 19.2
Advents 8 2.0
Other 2 0.5
Marital status
Single 73 18.2
Married 138 34.4
Divorced/Separated 72 18
Widowed 118 29.4
Occupation
Self employed 195 48.6
Salary earners 68 17.0
Peasant farmers 55 13.7
Housewife 23 5.7
None 59 14.7
Student 1 0.2
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THM compared to those who could tell it improves on
the health of an individual.
Multivariate analysis
The risk factors that were independently associated with
a decrease in THM use included; Young patients (≤38
years), HAART adherence levels ≤ 95%, patients on
HAART for < 4 years, participants who experienced
HAART side effects, not sexually active and those who
could not tell that THM improves on the health of an
individual and statistical significance was achieved
(Table 7).
Discussion
The prevalence of traditional herbal medicine use
among patients on HAART in TASO Uganda was high
with one in every three patients using herbs alongside
HAART. However, this prevalence of THM use may
be an underestimate of the true prevalence because we
used self-reports to assess herbal medicine use. Some
patients may not have reported herbal medicine use
alongside HAART since it is usually discouraged by
the health care providers. Our study was done in a set-
ting where patients are sensitized on the dangers of
combining conventional drugs like HAART with THM
and patients are followed up to monitor their progress.
The training of traditional herbalists in good practices
of herbal dispensing may promoted THM use hence
high prevalence. The training was conducted by the
WHO in association with the Tradition and Modern
Table 2 The prevalence of traditional herbal medicine
use among patients on HAART at TASO Uganda, during
2008
Variable Herbal
users
Prevalence
of THM use
95% CI
Overall herbal use 135/401 33.7 29.1 - 38.4
Sex
Men 33/121 27.3 19.9 - 35.7
Women 102/280 36.4 30.9 - 42.1
Age (categorized at
median age)
≤ 38 years 56/211 26.5 25.8 - 27.2
≥ 39 years 79/190 41.6 41.0 - 42.2
Religion
Christian 120/326 36.6 31.7 - 42.1
Muslim 15/73 20.5 12.4 - 30.9
Marital Status
Single 101/263 38.4 32.6 - 44.3
Married 34/138 24.6 17.9 - 32.3
Highest education level
attained
Primary 69/204 33.8 27.5 - 40.5
Secondary 45/130 34.6 26.8 - 43.1
Tertiary 4/13 30.8 10.6 - 58.7
None 17/54 31.5 20.1 - 44.7
Occupation
Employed 83/263 31.6 21.6 - 37.3
Not employed 52/138 37.7 29.8 - 45.9
Location
Urban 74/206 35.9 25.9 - 42.6
Rural 61/195 31.3 25.0 - 38.0
Site
Entebbe 57/168 33.9 27.0 - 41.3
Jinja 78/233 33.5 27.6 - 39.7
Table 3 Reasons and dosage for herbal medicine use
among patients on HAART at TASO Uganda, during 2008
Variable Frequency
(N = 135)
Percent
***Reasons for herbal use
Constant Fever 91 67.4
Too much Cough 88 65.2
General pain of HIV 71 52.6
Itchy skin 58 43.0
Others 58 43.0
To gain Energy 52 38.5
Was Anemic 39 28.9
Always fall sick 39 28.9
Low immunity 19 14.1
Loss/gain Appetite 18 13.3
Diarrhea 16 11.9
Too much sweat 11 8.1
Herbal dosage per day
Half to one cup/glass 128 94.8
One to two spoons 60 44.4
No measurements 17 12.6
Where herbs were got from
Herbalist 54 40
Garden 63 46.7
Friends/relatives 14 10.4
Pharmacy 4 7
**Experienced improvement with
use of herbs
Yes 130 96.3
Cannot tell 5 3.7
Decision of herbal use
Friends 71 52.6
Parents/Relatives 38 28.1
Own decision/No one 26 19.3
Patient’s belief/perception of
usefulness of ARVS
ARVs not yet helpful 35 25.9
ARVs helpful 100 74.1
** including all those who had ever used herbs before and after initiation on
HAART
***Others include body swells (1.17%) vaginal wounds (1.01%), syphilis (1.17%),
TB (0.67%), painful legs (1.17%), herpes (1%) and others
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other Diseases (THETA), community based organiza-
tion in Uganda.
Most of the literature reports CAM among HIV
patients with THM being just a part of CAM [14].
This makes it difficult for us to make good compari-
son. Nevertheless, other studies show a higher preva-
lence of CAM than the THM we found in our study.
In British Colombia the prevalence of herbal medicine
use among patients on was 19%[15]. The prevalence of
THM use in our study is lower than that found in the
USA where 67% of HIV patients were taking herbs, of
which 20% were taking Chinese herbs, in one study
[14] and less than 8% in Eastern Massachusetts and
Rhode Island[16]. The later however, considered both
patients on HAART and those not on HAART. The
latter are likely to use THM more. In Canada, 30% of
the HIV out patients reported use of herbs, [17]. THM
like CAM use was high among the HIV-positive popu-
lation and was primarily used to improve general
health in the USA [14,16,18]. The general lower preva-
lence of herbal medicine use among HIV patients in
Table 4 Type of herbal medicine used to treat symptoms of HAART among patients at TASO Uganda, during 2008
Type of herb taken Biological names N = 135
(%)
Symptoms treated
Mpafu/jjlikiti/ Canariu m schwcimf urthii Fever, Cough, Weakness
Erythrina abyssinica
Kasaana/
Mwooloola/ Entanda abyssinica 115(85.2)
Ovakedo Bersea Americana
P s i d i um guajava
Amapeera Mangifera in dica
Miyembe (leaves)
Other Herbs Just mentioned as “others” 86(63.7) Joint pains, Fever, cough
Kadomola mixture Can be mixture of food juice, or bark trees
and s t e m s
84(62.2) Fever, Cough, oral thrash, stomach wounds, HIV pain,
appetite, Diarrhea, body heat
Plant roots and stems
boiled
78(57.8) Fever, cough, back ace
Kigagi Aloe Vera 76(56.3) Fever
Don’t know name of herb 62(45.9) Fever, body heat, energy
Bazukuza Bafu Hibiscus 61(45.2) Anemia
Kamunye Herb Hoslundia opposite 41(30.4) Fever, stomach wounds
Molinga Herb Oleifera 35(25.9) Fever, weakness, appetite
Muzukizi Herb Dicliptere laxata 33(24.4)
Kamwanyi Herb 31(23.0) Fever
Mululuza Herb Vernonia a mygdalina 29(21.5) Fever
Boombo Herb Memodica f eo tida 26(19.3) Cough
Naloongo Herb Justicia betonica 21(15.6) Fever
Kikakala Herb 21(15.6)
Nim tree Herb 20(14.8)
Kanzironziro Herb P sorospermum febrifugum 20(14.8) Body weakness
Olubirizi Herb Vernonia a mygdalina 18(13.3)
Musita Herb Albizia cariaria 17(12.6)
Nakakasero Herb 16(11.9) Fever
Own Urine (morning
personal urine)
- 15(11.1) HIV generally
Ngetwa Herb Consists of 54 herbs (mainly from
Tanzania)
15(11.1) Cough, fever, appetite, stomach pain, headache
Olusazisazi Herb Cassia occidentalis 12(8.9)
Kambula Herb Cardiospermu m granflor um 9(6.7) 7(5.2)
Herbal Soap and jelly - Skin rash
Pressure herbs - 4(3.0) High blood pressure,
Most of the herbs were boiled and orally administered
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(14%) of herbal/supplemental use in the population
[14,16,18].
In our study, the prevalence of THM use among the
women was higher than that in men, but this was not
statistically significant. A similar trend has been
observed in large surveys in the USA[14,16,18]. Age was
associated with THM use in our study, and was statisti-
cally significant. This is in contrast to findings from the
study in British Columbia[15] where there was no asso-
ciation between age and THM use.
It is not surprising that, individuals who were on
HAART for a relatively short period of time also use
THM more than those who on HAART for more than
four years in our study. This is in contrast to a study by
Agnoletto et al where patients with longer duration on
HAART are more likely to use CAM[7]. It is possible
that these patients had not yet been well sensitized
about not using herbs alongside HAART or they had
been using THM before they were enrolled on HAART.
Our study showed HAART side effects like anemia
and HIV related symptoms (fever, cough, joint pain, oral
thrash, etc.), were the main reasons for THM use. This
is possibly due to the information provided by tradi-
tional herbalists that THM are natural foods without
any toxic element that give good relief if eaten in good
quantities. There is Increasing proof of the interactions
of herbs/supplement and HAART with potential for ser-
ious adverse effects[11,12]. Some herbs (e.g., germander,
comfrey, pennyroyal) have well-documented toxic effects
[19]. Our study could not clearly establish the adverse
effects of THM since we mainly focused on THM use.
However a study by Hsiao et al[12] in the United States
focused on potential adverse effects found one quarter
of the CAM to have adverse effects. THM and
HAART may share similar adverse effects. Patients
using both therapies may wrongly attribute their
adverse effects to the antiretroviral. Interactions of this
type may result in increased toxicity and decreased
efficacy of both THM and HAART[20]. We found out
that some clinicians also advise and prescribe patients
to use the anemia herb. Clinicians who are not aware
of their patients’ u s eo fT H Mm a yc h a n g ea n t i r e t r o -
viral regimens unnecessarily.
Table 5 Bivariate analysis of socio-demographic factors and herbal medicine use among patients on HAART at TASO
Uganda, during 2008
Variable Used herbal
N = 135(%)
Not used herbal
N = 266 (%)
Unadjusted OR (95%CI) P- value
Sex
Male 33 (24.4) 88 (33.1) 1.00 0.076
Female 102 (75.6) 178 (66.9) 0.65 (0.4 - 1.05)
Age (categorized at median age)
≤ 38 years 56 (41.5) 155 (58.3) 1.00 0.002
≥ 39 years 79 (58.5) 111 (41.7) 0.51 (0.33 - 0.77)
*Religion
Catholic 42 (31.11) 67 (25.19) 1.59 (0.097 - 26.1) 0.74
Protestant 49 (36.30) 83 (31.20) 1.69 (0.01 - 27.6) 0.71
Muslim 15 (11.11) 58 (21.80) 3.86 (0.2 - 65.4) 0.34
Pentecost 24 (17.78) 53 (19.92) 2.2 (0.13 - 36.8) 0.58
Other 5 (3.70) 5 (1.88) 1.00
Marital Status
Married 34 (25.2) 104 (39.1) 1.00 0.006
Not married 101 (74.8) 162 (60.9) 1.91 (1.20 - 3.02)
Highest education level attained
Primary 69 (51.11) 135 (50.75) 1.00
Secondary 45 (33.33) 85 (31.95) 0.97 (0.61 -1.54) 0.882
Tertiary 4 (2.96) 9 (3.38) 1.15 (0.34 - 3.88) 0.822
None 17 (12.59) 37 (13.91) 1.11 (0.58 - 2.12) 0.746
Occupation
Self employed 62 (45.93) 133 (50.00) 1.00
Salaried employed 21 (15.56) 47 (17.67) 1.04 (0.57 - 1.90) 0.889
None 30 (22.22) 53 (19.92) 0.82 (0.48 - 1.41) 0.481
Peasant 22 (16.30) 33 (12.41) 0.70 (0.38 - 1.30) 0.256
*overall p value 0.11
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with THM, before and after enrolling on HAART could
possibly be true. On the other hand, it could be due to
H A A R Ta sw e l la sc a r ea n ds u p p o r tp r o v i d e db yt h e
counselors and clinicians at the treatment centres. This
was referred to as positive outcome due to herbal use,
but was not clinically assessed by the study. “It is not
unreasonable to suggest that some herbal products may
have therapeutic benefits”, Edward Mills reported[21]. A
randomized clinical trial in China reported promising
effects from three herbal medicines and combined treat-
ment of herbal medicine and ARV agents showed
increased antiviral benefits compared to ARVs alone[5].
In addition, almost no pharmacokinetic interaction stu-
dies so far have been conducted with HIV-infected
patients[11]. Pharmacological investigations would be
prudent to identify the potential risks, benefits, and
interaction or noninteractions associated with HAART
and local THM use in Uganda.
Adherence to antiretroviral medication in the treat-
ment of HIV is critical, both to maximize efficacy and
to minimize the emergence of drug resistance[22].
Patients whose HAART adherence level was below
95% were more likely to use THM. This is similar to
what Kiguba et at[13] found out in Uganda, although
h i so u t c o m ew a sn o tT H Ma si no u rs t u d y .I nZ a m b i a ,
half of the pregnant women with low adherence to
Nevirapine were using THM [23]. In KwaZulu-Natal,
South-Africa, results indicated that the use of herbal
therapies for HIV declined significantly from 36.6%
prior to HAART initiation to 7.9% after being on
ARVs for 6 months[24]. However, the study designs
Table 6 Bivariate analysis of drug related and individual factors associated with THM use among patients on HAART
at TASO, during 2008
Variable Used herbal
N = 135(%)
Not used herbal
N = 266 (%)
Unadjusted Odds ratio (95%CI) P- value
Duration on HAART
≥ 4 years 25 (18.5) 30 (11.3) 1.00 0.064
< 4 years 110 (81.5) 236 (88.7) 1.79 (1.00 - 3.18)
Ever experienced side effects
No 50 (37.0) 146 (54.5) 1.00 0.001
Yes 85 (63.0) 121 (45.5) 2.04(1.33 - 3.12)
Adherence level in the last 3 months*
75% - 95% 3 (6.1) 8 (9.4) 1.00 0.74
> 95% 46 (93.9) 77 (90.6) 0.6 (0.1 - 2.4)
Duration on herbs while on HAART
< 6 months 30 (22.22) 35 (43.8) 1.00
6 - 12 months 35 (25.93) 16 (20.0) 0.39 (0.18 - 0.86) 0.016
More than a year 70 (51.85) 29 (36.3) 0.35 (0.18 - 0.70) 0.002
Ever changed regimen
Yes 39 (28.89) 45 (16.92) 1.00
No 96 (71.11) 221 (83.08) 2.00 (1.21 - 3.28) 0.006
Herbs improved health
Yes 130(96.2) 64() 1.00
Cannot tell 5(3.8) 16(6.02) 2.64 (1.71 - 4.08) P < 0.001
Familiar with herbs
Yes 135 (100) 218 (82.0) 1.00 P < 0.001
No 0 48 (18.0) 0.62 (0.577 - 0.67)
Outcome expectation of Herbs
Yes 135 (100) 62 (77.5) 1.00 P < 0.001
No 0 18 (22.5) 0.32 (0.25 - 0.39)
Sexually active patients*
Yes 100 (74.60) 120 (62.50) 1.00
No 34 (25.40) 72 (37.50) 0.57 (0.35 - 0.92) 0.023
Disclosure of HIV to others Status
Yes 119 (88.1) 207 (77.8) 1.00
No 16 (11.9) 59 (22.2) 2.12 (1.16 - 3.85) 0.012
*Missing values
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comparable.
Limitations of the study
Study participants were well informed about HAART
making them a unique population. This would be differ-
ent if study was done on a different population for
example in general hospitals that provide HAART in
Uganda, where emphasizes on the dangers of mixing
conventional drugs with THM is very minimal. On the
other hand THM use was self-reported. It is plausible
that some respondents were hesitant to report actual
THM use, and possibly fearing to be reprimanded or
denied further HAART care. To some extent, this could
have biased or resulted to an underestimation of our
results, because, if one reported use, then he actually
d i dc o m b i n et h eT H Ma n dH A A R T .I ti sp l a u s i b l et h a t
we would have got more accurate results, if the inter-
views were not carried out at the treatment Centre.
Adherence was not fully assessed due to missing and/or
incomplete data. Most patients reported weight gain
after using herbs for some time. We could not verify
this self-report for our study design could not enable us
measure causality.
Conclusions
There is a wide spread use of traditional herbal medi-
cines concurrently with antiretroviral drugs. Potential
beneficial effects need to be confirmed in large, rigorous
designed trials or large survey researches. Although
guidelines of herbal use is still lacking in the country, it
is important that herbal medicine use be monitored
among HAART patients in case of any drug interactions
or resistance.
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